Inflammatory Bowel Disease: Updates on Molecular Targets for Biologics

Therapy for inflammatory bowel disease (IBD) has changed, with several new agents being evaluated. The era of anti-tumor necrosis factor (anti-TNF) antibody therapy saw remarkable progress in IBD therapy. Some patients, however, do not respond to anti-TNF treatment, or their response decreases over...

Descripción completa

Detalles Bibliográficos
Autores principales: Katsanos, Konstantinos H., Papadakis, Konstantinos A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491079/
https://www.ncbi.nlm.nih.gov/pubmed/28486793
http://dx.doi.org/10.5009/gnl16308

Ejemplares similares

Ejemplares similares